Profile data is unavailable for this security.
About the company
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
- Revenue in USD (TTM)16.00m
- Net income in USD3.10m
- Incorporated2013
- Employees42.00
- LocationCV Sciences Inc9530 PADGETT STREET, SUITE 107SAN DIEGO 92126United StatesUSA
- Fax+1 (619) 876-4321
- Websitehttps://cvsciences.com/
More ▼
Mergers & acquisitions
| Acquired company | CVSI:QBB since announced | Transaction value |
|---|---|---|
| Cultured Foods Sp z o o | 10.00% | 568.00k |
Data delayed at least 15 minutes, as of May 03 2024 20:58 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kintara Therapeutics Inc | 0.00 | -10.77m | 6.14m | 2.00 | -- | -- | -- | -- | -5.98 | -5.98 | 0.00 | -0.0157 | 0.00 | -- | -- | 0.00 | -179.36 | -220.94 | -316.27 | -329.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 40.24 | -- | 78.93 | -- |
| Theralink Technologies Inc | 635.46k | -13.50m | 6.15m | 16.00 | -- | -- | -- | 9.68 | -0.0027 | -0.0027 | 0.00006 | -0.0093 | 0.2525 | -- | 13.51 | 39,716.25 | -536.39 | -- | -- | -- | 73.50 | -- | -2,124.10 | -- | -- | -1.35 | -- | -- | 6.85 | -- | -138.38 | -- | -- | -- |
| Creative Medical Technology Holdings Inc | 9.00k | -5.29m | 6.17m | 4.00 | -- | 0.6042 | -- | 685.85 | -3.76 | -3.76 | 0.0064 | 7.53 | 0.0006 | 0.4291 | -- | 2,250.00 | -35.36 | -110.00 | -40.34 | -- | 60.00 | 65.82 | -58,739.67 | -7,961.14 | 27.64 | -- | 0.00 | -- | -89.84 | -40.86 | 47.88 | -- | -- | -- |
| Ainos Inc | 122.11k | -13.77m | 6.19m | 46.00 | -- | 0.199 | -- | 50.71 | -3.32 | -3.32 | 0.0298 | 5.23 | 0.0035 | 0.9854 | 1.21 | 2,654.57 | -39.94 | -36.36 | -42.28 | -58.33 | -207.80 | 36.82 | -11,277.18 | -813.63 | 1.72 | -91.59 | 0.1961 | -- | -96.53 | 9.46 | 1.69 | -- | 66.44 | -- |
| Palisade Bio Inc | 250.00k | -12.30m | 6.21m | 9.00 | -- | 0.3984 | -- | 24.83 | -28.22 | -28.22 | 0.5485 | 18.30 | 0.0168 | -- | 0.3153 | 27,777.78 | -82.51 | -132.36 | -101.58 | -165.45 | -- | -- | -4,920.00 | -27,892.32 | -- | -856.33 | 0.0138 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
| TFF Pharmaceuticals Inc | 733.87k | -21.24m | 6.22m | 19.00 | -- | 0.6119 | -- | 8.48 | -12.67 | -12.67 | 0.4097 | 4.04 | 0.0406 | -- | 2.37 | 38,624.74 | -117.54 | -79.57 | -130.37 | -83.41 | -- | -- | -2,894.69 | -8,687.66 | -- | -- | 0.00 | -- | 48.01 | -- | 33.13 | -- | -- | -- |
| CV Sciences Inc | 16.00m | 3.10m | 6.31m | 42.00 | 1.87 | 2.15 | 1.89 | 0.3942 | 0.0206 | 0.0206 | 0.104 | 0.018 | 1.46 | 1.46 | 26.74 | 381,047.60 | 28.28 | -43.42 | 247.47 | -77.75 | 44.27 | 51.81 | 19.38 | -45.68 | 0.3733 | 13.68 | 0.0805 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| CeCors Inc | -100.00bn | -100.00bn | 6.31m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| Azitra Inc | 686.00k | -12.64m | 6.33m | 10.00 | -- | 0.9132 | -- | 9.23 | -2.99 | -2.99 | 0.0713 | 0.2408 | 0.1117 | -- | 4.88 | 68,600.00 | -183.73 | -- | -266.83 | -- | -- | -- | -1,644.87 | -- | -- | -45.86 | 0.0138 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
| Kineta Inc | 5.44m | -14.10m | 6.37m | 11.00 | -- | 2.02 | -- | 1.17 | -1.43 | -1.43 | 0.5297 | 0.278 | 0.3927 | -- | -- | 494,727.30 | -101.57 | -66.16 | -318.39 | -86.61 | -- | -- | -258.65 | -854.74 | -- | -1,310.25 | 0.2011 | -- | 178.65 | 13.89 | 77.76 | -- | -- | -- |
| Sentient Brands Holdings Inc | 160.00 | -379.70k | 6.37m | 2.00 | -- | -- | -- | 39,829.26 | -0.007 | -0.007 | 0.00 | -0.0308 | 0.0006 | -0.0026 | -- | 80.00 | -149.74 | -224.47 | -- | -- | 462.50 | 41.35 | -237,312.50 | -27,393.23 | 0.0005 | -0.6995 | -- | -- | -16.18 | -- | -100.19 | -- | -- | -- |
| Stemtech Corp | 4.64m | -4.08m | 6.37m | 45.00 | -- | -- | -- | 1.37 | -0.0624 | -0.0624 | 0.0619 | -0.0092 | 1.09 | 8.35 | 65.16 | 103,098.40 | -96.70 | -- | -- | -- | 76.09 | -- | -88.58 | -- | 0.1045 | -1.81 | 2.27 | -- | -- | -- | -- | -- | -- | -- |
| Processa Pharmaceuticals Inc | 0.00 | -11.12m | 6.45m | 13.00 | -- | 0.5825 | -- | -- | -8.72 | -8.72 | 0.00 | 3.88 | 0.00 | -- | -- | 0.00 | -154.40 | -84.35 | -175.45 | -90.03 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Lixte Biotechnology Holdings Inc | 0.00 | -5.09m | 6.48m | 3.00 | -- | 13.10 | -- | -- | -2.77 | -2.77 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -103.09 | -104.18 | -111.07 | -111.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to CV Sciences Inc's reporting currency: US Dollar USD
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MML Investors Services LLCas of 31 Mar 2024 | 5.00k | 0.00% |
| TriVant Custom Portfolio Group LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
